发明名称 METHOD FOR DETERMINING INDICATIONS TO LASER THERAPY FOR TREATING THE PATIENTS SUFFERING FROM NONSPECIFIC PULMONARY DISEASES
摘要 medicine. SUBSTANCE: method involves carrying out whole blood luminol - dependent chemiluminescence examination using special device. 0.1 ml of heparin-treated patient blood (50 units of heparin per 1 ml of blood) is added to 2 ml of physiological salt solution with 0,1.10-5 M of luminol and spontaneous chemiluminescence is recorded during 10 min. To study induced spontaneous chemiluminescence, 0.1 ml of patient blood is mixed with 0.01 ml of one day old staphylococcus culture (109 of microbial cells in 1 ml) and incubated during 2 min. Physiological salt solution mixed with luminol is added. Drop in values of spontaneous whole blood chemiluminescence like spontaneous luminescence being less than 0.35 relative units, luminescence photosum being less than 8.0 relative units, the like values in the case of induced spontaneous luminescence being less than 1.4 and 30.0 relative units, respectively, inhibited active oxygen forms production is diagnosed in which intravascular blood laser irradiation is indicated and effective. Increase in whole blood chemiluminescence like spontaneous luminescence being greater than 0.45 relative units, luminescence photosum being greater than 10.0 relative units, the like values in the case of induced spontaneous luminescence being greater than 2.0 and 50.0 relative units, respectively, increased active oxygen forms production is diagnosed in which intravascular blood laser irradiation is contraindicated. EFFECT: enhanced effectiveness of treatment.
申请公布号 RU2177153(C1) 申请公布日期 2001.12.20
申请号 RU20000132347 申请日期 2000.12.22
申请人 BASHKIRSKIJ GOSUDARSTVENNYJ MEDITSINSKIJ UNIVERSITET 发明人 FARKHUTDINOV U.R.;ABDRAKHMANOVA L.M.;FARKHUTDINOV SH.U.;GOLOVANOV N.V.
分类号 G01N33/483;G01N33/52 主分类号 G01N33/483
代理机构 代理人
主权项
地址